Icure Pharmaceutical Incorporation (175250) — Cash Flow Reinvestment Rate
Icure Pharmaceutical Incorporation (175250) has a Cash Flow Reinvestment Rate of 83.70x as of June 2020, reinvesting ₩16.36 Billion (capex ₩7.44 Billion plus investments ₩8.92 Billion) from operating cash flow of ₩195.44 Million. Explore 175250 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Icure Pharmaceutical Incorporation Cash Flow Reinvestment Rate (2017–2017)
Historical reinvestment intensity for Icure Pharmaceutical Incorporation across 1 annual periods. Also explore 175250 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Icure Pharmaceutical Incorporation (2017–2017)
Year-by-year capital reinvestment analysis for Icure Pharmaceutical Incorporation. For live market cap and broader valuation context, see Icure Pharmaceutical Incorporation market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 9.20x | ₩10.30 Billion | ₩1.12 Billion | ₩10.10 Billion | — |